TCR sequencing to track cancer immunity
The Genomics Core Research Facility is enabling researchers to investigate what causes T-cells to drive a negative or positive immune response to cancers. This knowledge is being used to inform the development of tailored vaccines using a neoantigen approach to eradicate cancerous tumours.
Areas of research
Associate Professor Mark Watson and Associate Professor Abha Chopra